2023-07-02 19:35:49
The new director of Inmegen is a graduate of the Anahuac University and has a master’s degree and doctorate in Sciences from the Faculty of Sciences of the UNAM.
He has also published more than 120 research articles in international and national journals and eight book chapters.
His lines of research focus on genomic medicine, cancer, cell death, stem cells, gene editing, and transduction cascades.
After an extensive process, the new director of the National Institute of Genomic Medicine (Inmegen). In this case, it is Jorge Meléndez Zajgla, who protested this position in a ceremony led by the head of the Ministry of Health (SSa), Jorge Alcocer Varela.
The ceremony was carried out with the presence of the head of the Coordinating Commission of National Institutes of Health and High Specialty Hospitals (CCINSHAE), Gustavo Reyes Terán; the general director of Coordination of the National Institutes of Health, Carla del Carmen Toledo Salinas; members of the Governing Board, as well as directors and general directors of institutes and hospitals.
In your message, Melendez Zajgla He pointed out that it is time to apply the science that has been developed at the institute, in products and services for the national medical community and for patients throughout the country.
“It is very important that Inmegen’s work is translated into implementation science in order to have a tangible impact on the health of Mexicans.”
He new director general of Inmegenwho took office for the 2023-2028 period, also stated that he will strengthen transparency in all the institute’s activities, and considered it essential that the public and the scientific community fully trust Inmegen and use the resources assigned to it appropriately. institution.
Training and trajectory of the new director of Inmegen
Jorge Meléndez Zajgla is a surgeon from the Anahuac University. He obtained master’s and doctorate degrees in Sciences from the Faculty of Sciences of the National Autonomous University of Mexico (UNAM). He is a researcher in Medical Sciences “F”, attached to the Inmegen Functional Genomics laboratory and a member of the National System of Researchers (SNII) Level 3, in addition to being a full member of the National Academy of Medicine.
In 2007 he began the line of research “Functional Genomics”, which includes projects aimed at elucidating the genomic bases of human diseases, among other topics. The results of his research have made an important contribution to studies in the diagnosis and treatment of various types of cancer.
Meléndez Zagla has published more than 120 research articles in international and national journals and eight book chapters. He has also been quoted about 14,000 times in articles published in prestigious specialized magazines such as Science, Nature, PNAS, JBC, Oncogene y EMBO Reports.
He is a magazine editor. Scientific Reports, Clinical and Translational Oncology, Frontiers in Genetics y Frontiers in Oncology, among other. He has directed 34 theses, including five postdoctoral, ten doctoral, four master’s, five specialty and 12 undergraduate.
He is a professor or tutor of the postgraduate courses in Biological Sciences, Biomedical Sciences and Medical Sciences at UNAM, including tenured professor of the High Specialty Course of Genomic Medicine in Cancer UNAM-Inmegen. He has received nine awards and distinctions, such as the “Marcos Moshinsky” Chair and the “Heberto Castillo” Award. He highlights his participation as a member of the Scientific Steering Committee del International Cancer Genome Consortiumthe largest global initiative to elucidate the cancer genome.
His lines of research focus on issues of genomic medicine, cancer, cell death, stem cells, gene editing and transduction cascades.
Also read:
Inmegen turns 18: Pilar in genetic sampling in Mexico
Mexican obesity could be due to genetic factors: Inmegen
Mexico has unique technology to detect pediatric dementia
#Inmegen #director #Jorge #Meléndez #Zajgla